This trial is active, not recruiting.

Conditions stomach cancer, colon cancer, thyroid cancer, breast cancer
Treatment brochure of secondary cancer screening
Phase phase 2
Sponsor National Cancer Center, Korea
Start date August 2009
End date November 2009
Trial size 326 participants
Trial identifier NCT00948337, NCS-09-266


The purpose of this study is to provide educational material to promote screening for second primary cancer for the intervention group, or educational material to instruct appropriate use of dietary supplement for the control group.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double blind (subject, investigator)
Primary purpose supportive care
brochure of secondary cancer screening
One kind of printed educational material
(Active Comparator)
brochure of secondary cancer screening
One kind of printed educational material

Primary Outcomes

Screening behavior for second primary cancer
time frame: After 1 yr

Secondary Outcomes

Knowledge and attitudes of Secondary cancer screening and dietary supplement
time frame: In 2 weeks

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - Age >=18, <80 - Cancer survivors (pathologically confirmed) - Finished primary treatment (surgery, radiotherapy, chemotherapy) - >= 1 year from cancer diagnosis - No evidence of recurrence, metastasis, and second primary cancer - No evidence of hereditary cancer - ECOG 0,1,2 - Ability in reading Korean educational material Exclusion Criteria: - ECOG 3,4 - Disagree with the investigators study purpose

Additional Information

Official title A Randomized Controlled Trial on the Effect of Intervention With Health Educational Material on Knowledge, Attitude, and Behavior in Cancer Survivors
Trial information was received from ClinicalTrials.gov and was last updated in February 2010.
Information provided to ClinicalTrials.gov by National Cancer Center, Korea.